Posted On: 06/13/2016 5:18:50 PM
Post# of 72447
That makes sense. It explains why Leo decided to go ahead with the B-UP trial instead of waiting on results from B-OM as had previously been indicated. Good results from B-UP and B-OM to go with the excellent results on ABSSSI and the possibilities for Brilacidin are staggering.
On top of that, if J&J (or whoever) is getting positive results from testing B as a medical device coating... Do you think perhaps a J&J type BP might decide that they need to go ahead and secure the Brilacidin franchise and it's $10 Billion+ in annual revenue potential?
Yeah. I can understand why Leo decided to go ahead with the B-UP POC trial...
On top of that, if J&J (or whoever) is getting positive results from testing B as a medical device coating... Do you think perhaps a J&J type BP might decide that they need to go ahead and secure the Brilacidin franchise and it's $10 Billion+ in annual revenue potential?
Yeah. I can understand why Leo decided to go ahead with the B-UP POC trial...
Quote:
Besides B-OM, I think Leo plans to wait for the B-UP data before partnering. The B-UP trial should be really quick because it’s open-label and the treatment is six weeks, as opposed to twelve weeks for P. - sox040713
(1)
(0)
